Yueping N. Liu

State Key Laboratory Of Bioreactor Engineering
Shanghai, 200237, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 298 publications

Integration of AI-Based Synthetic CT Generation and Auto-Segmentation for CBCT-Guided Adaptive Radiotherapy in Prostate Cancer: A Feasibility Study.

Integration of AI-Based Synthetic CT Generation and Auto-Segmentation for CBCT-Guided Adaptive Radiotherapy in Prostate Cancer: A Feasibility Study.

Journal: Cancers

Published: July 14, 2026

Correction: Surgical treatment and prognosis in patients with intestinal metastases originated from advanced epithelial ovarian cancer.

Correction: Surgical treatment and prognosis in patients with intestinal metastases originated from advanced epithelial ovarian cancer.

Journal: Frontiers in oncology

Published: July 10, 2026

Benzoic acid inhibits peach root growth and lateral root emergence by disrupting auxin homeostasis through salicylic acid accumulation.

Benzoic acid inhibits peach root growth and lateral root emergence by disrupting auxin homeostasis through salicylic acid accumulation.

Journal: Plant cell reports

Published: July 03, 2026

Deep learning-based assessment of HER2-ultralow expression in breast cancer: a multi-center validation study across primary and metastatic lesions.

Deep learning-based assessment of HER2-ultralow expression in breast cancer: a multi-center validation study across primary and metastatic lesions.

Journal: Virchows Archiv : an international journal of pathology

Published: April 15, 2026

Dose-Escalated Versus Standard Neoadjuvant Chemoradiation Therapy for Locally Advanced Rectal Cancer: Nine-Year Results of a Randomized Phase 2 Trial.

Dose-Escalated Versus Standard Neoadjuvant Chemoradiation Therapy for Locally Advanced Rectal Cancer: Nine-Year Results of a Randomized Phase 2 Trial.

Journal: International journal of radiation oncology, biology, physics

Published: April 14, 2026

Multimodal artificial intelligence predicts PIK3CA mutation in breast cancer from digital pathology and clinical data: a multicenter study.

Multimodal artificial intelligence predicts PIK3CA mutation in breast cancer from digital pathology and clinical data: a multicenter study.

Journal: Cancer biology & medicine

Published: April 13, 2026

Effect comparison between a new hypofractionated radiotherapy regimen and conventional moderately hypofractionated regimen for localized prostate cancer.

Effect comparison between a new hypofractionated radiotherapy regimen and conventional moderately hypofractionated regimen for localized prostate cancer.

Journal: Radiation oncology (London, England)

Published: March 29, 2026

Enhancing lymph node metastases assessment in breast cancer post-neoadjuvant therapy using artificial intelligence-driven diagnostics.

Enhancing lymph node metastases assessment in breast cancer post-neoadjuvant therapy using artificial intelligence-driven diagnostics.

Journal: Breast cancer research : BCR

Published: March 18, 2026

Hydrophobic Zn-doped CuO catalysts with sharp edges promote asymmetric CC coupling for selective ethylene electrosynthesis from CO2 reduction.

Hydrophobic Zn-doped CuO catalysts with sharp edges promote asymmetric CC coupling for selective ethylene electrosynthesis from CO2 reduction.

Journal: Journal of colloid and interface science

Published: March 16, 2026

MEOX1 Inhibits Growth and Metastasis of Salivary Adenoid Cystic Carcinoma.

MEOX1 Inhibits Growth and Metastasis of Salivary Adenoid Cystic Carcinoma.

Journal: Current issues in molecular biology

Published: March 11, 2026

Prognostic stratification value of MLH1 promoter methylation in endometrioid endometrial carcinomas with a dMMR molecular phenotype

Prognostic stratification value of MLH1 promoter methylation in endometrioid endometrial carcinomas with a dMMR molecular phenotype

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: March 08, 2026

HER2-low as a unique subgroup in breast cancer: insights from neoadjuvant chemotherapy response and survival analysis.

HER2-low as a unique subgroup in breast cancer: insights from neoadjuvant chemotherapy response and survival analysis.

Journal: Journal of clinical pathology

Published: March 08, 2026

Showing 1-12 of 298

Last Updated: 09/26/2026